Volcano Adds CardioSpectra High-Res Imaging To Intravascular Portfolio

Intravascular imaging firm Volcano hopes to have an application before FDA for optical coherence tomography sometime next year after inking a deal worth up to $63 million to acquire the technology developer CardioSpectra